NCT06786390 Improved Recovery of Walking in Acquired Muscle Weakness
| NCT ID | NCT06786390 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Don Carlo Gnocchi ETS |
| Condition | Critical Illness Myopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-02-25 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of Re-Walk-Easy is to evaluate the effects of rehabilitation based on electrical stimulation on the motor performance of critically ill patients. The study will also investigate the pathophysiology of the two forms-the myopathic-predominant and the polyneuropathic-predominant variants-by examining the longitudinal progression of CIP and CIM and determining which form benefits more from electrical stimulation as a rehabilitative approach.
Eligibility Criteria
Critical Illness Patient Inclusion Criteria: * clinical diagnosis of tetra/paraparesis of peripheral origin as disclosed by ENG/EMG examination; * be independent before the episode of critical illness Critical Illness Patient Exclusion Criteria: * history of previous comorbidity for ICU-AW; * previous known chronic polyneuropathy; * severe coagulopathy; * severe disorder of consciousness; * contraindications to Electrical Stimulation application Healthy Subjects Exclusion Criteria: * Prosthetic implants * musculoskeletal, neurological, cardiovascular and pulmonary disorders that may alter the gait
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06786390 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Critical Illness Myopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786390 currently recruiting?
Yes, NCT06786390 is actively recruiting participants. Contact the research team at tlencioni@dongnocchi.it for enrollment information.
Where is the NCT06786390 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06786390 clinical trial?
NCT06786390 is sponsored by Fondazione Don Carlo Gnocchi ETS. The trial plans to enroll 72 participants.